Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2

Endocrinology

Volumn 150, Issue 1, 2009, Pages 452-462

  Winn, Virginia D ^a,c   Gormley, Matthew ^a   Paquet, Agnes C ^b   Kjaer Sorensen, Kasper ^e   Kramer, Anita ^c   Rumer, Kristen K ^c   Haimov Kochman, Ronit ^a,b   Yeh, Ru Fang ^b   Overgaard, Michael T ^e   Varki, Ajit ^d   Oxvig, Claus ^e   Fisher, Susan J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBIN; LEPTIN; LEPTIN RECEPTOR; PAPPALYSIN 2; PROTEINASE; SIALIC ACID; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN 6; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFECTION; MOTHER FETUS RELATIONSHIP; PATHOGENESIS; PLACENTA; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SYNCYTIOTROPHOBLAST; VALIDATION PROCESS;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LECTINS; MATERNAL-FETAL EXCHANGE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

EID: 58149461540     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0990     Document Type: Article

References (63)

1. Roberts JM, Cooper DW 2001 Pathogenesis and genetics of pre-eclampsia. Lancet 357:53-56
2. Gomez O, Martinez JM, Figueras F, Del Rio M, Borobio V, Puerto B, Coll O, Cararach V, Vanrell JA 2005 Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet Gynecol 26:490-494
3. Hershkovitz R, de Swiet M, Kingdom J 2005 Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler. Hypertens Pregnancy 24:273-280 452-462
4. Brosens IA, Robertson WB, Dixon HG 1972 The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1:177-191
5. Gerretsen G, Huisjes HJ, Elema JD 1981 Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 88:876-881
6. Moodley J, Ramsaroop R 1989 Placental bed morphology in black women with eclampsia. S Afr Med J 75:376-378
7. Khong TY, De Wolf F, Robertson WB, Brosens I 1986 Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93:1049-1059
8. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK 1989 Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161: 1200-1204
9. Roberts JM 1998 Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16:5-15
10. Friedman SA, Schiff E, Emeis JJ, Dekker GA, Sibai BM 1995 Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol 172:202-203
11. Hsu CD, Iriye B, Johnson TR, Witter FR, Hong SF, Chan DW 1993 Elevated circulating thrombomodulin in severe preeclampsia. Am J Obstet Gynecol 169:148-149
12. Taylor RN, Crombleholme WR, Friedman SA, Jones LA, Casal DC, Roberts JM 1991 High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol 165:895-901
13. Tyurin VA, Liu SX, Tyurina YY, Sussman NB, Hubel CA, Roberts JM, Taylor RN, Kagan VE 2001 Elevated levels of S-nitrosoalbumin in preeclampsia plasma. Circ Res 88:1210-1215
14. Clark BA, Halvorson L, Sachs B, Epstein FH 1992 Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol 166:962-968
15. Mills JL, DerSimonian R, Raymond E, Morrow JD, Roberts 2nd LJ, Clemens JD, Hauth JC, Catalano P, Sibai B, Curet LB, Levine RJ 1999 Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA 282:356-362
16. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA 2006 Soluble endog-lin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355:992-1005
17. Winn VD, Haimov-Kochman R, Paquet AC, Yang YJ, Madhusudhan MS, Gormley M, Feng KT, Bernlohr DA, McDonagh S, Pereira L, Sali A, Fisher SJ 2007 Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between rnidgestation and term. Endocrinology 148:1059-1079
18. Zhou Y, Bianco K, Huang L, Nien JK, McMaster M, Romero R, Fisher SJ 2007 Comparative analysis of the maternal-fetal interface in preeclampsia and pre-term labor. Cell Tissue Res 329:559-569
19. American College of Obstetricians and Gynecologists 1999 Practice bulletin 10. Induction of labor. Washington, DC: American College of Obstetricians and Gynecologists
20. Haimov-Kochman R, Fisher SJ, Winn VD 2006 Modification of the standard Trizol-based technique improves the integrity of RNA isolated from RNase-rich placental tissue. Clin Chem 52:159-160
21. Auer H, Lyianarachchi S, Newsom D, Klisovic MI, Marcucci G, Kornacker K 2003 Chipping away at the chip bias: RNA degradation in microarray analysis. Nat Genet 35:292-293
22. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J 2004 Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
23. Bolstad BM 2004 Low level analysis of high-density oligonucleotide array data: background, normalization and summarization. Dissertation, University of California, Berkeley
24. Smyth GK 2005 Limma: linear models for microarray data. In: Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S, eds. Bioinformatics and computational biology solutions Using R and Bioconductor. New York: Springer; 397-420
25. Brinkman-Van der Linden EC, Hurtado-Ziola N, Hayakawa T, Wiggleton L, Benirschke K, Varki A, Varki N 2007 Human-specific expression of Siglec-6 in the placenta. Glycobiology 17:922-931
26. Patel N, Brinkman-Van der Linden EC, Altmann SW, Gish K, Balasubramanian S, Timans JC, Peterson D, Bell MP, Bazan JF, Varki A, Kastelein RA 1999 OB-BP1/Siglec-6: a leptin- and sialic acid-binding protein of the immunoglobulin su-perfamily. J Biol Chem 274:22729-22738
27. Damsky CH, Fitzgerald ML, Fisher SJ 1992 Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest 89:210-222
28. Overgaard MT, Boldt HB, Laursen LS, Sottrup-Jensen L, Conover CA, Oxvig C 2001 Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. J Biol Chem 276:21849-21853
29. Ellgaard L, Holtet TL, Nielsen PR, Etzerodt M, Gliemann J, Thogersen HC 1997 Dissection of the domain architecture of the α2 macroglobulin-receptor-associated protein. Eur J Biochem 244:544-551
30. Anderson M, Blowers D, Hewitt N, Hedge P, Breeze A, Hampton I, Taylor I 1999 Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies. Protein Expr Purif 15:162-170
31. Harlow E. LD 1988 Antibodies: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
32. Oxvig C, Sand O, Kristensen T, Kristensen L, Sottrup-Jensen L 1994 Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. Bio-chim Biophys Acta 1201:415-423
33. Overgaard MT, Haaning J, Boldt HB, Olsen IM, Laursen LS, Christiansen M, Gleich GJ, Sottrup-Jensen L, Conover CA, Oxvig C 2000 Expression of re-cornbinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 275:31128-31133
34. Qin QP, Christiansen M, Oxvig C, Pettersson K, Sottrup-Jensen L, Koch C, Norgaard-Pedersen B 1997 Double-monoclonal immunofluorormtric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome. Clin Chem 43:2323-2332
35. McMaster MT, Librach CL, Zhou Y, Lim KH, Janatpour MJ, DeMars R, Kovats S, Damsky C, Fisher SJ 1995 Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 154:3771-3778
36. American College of Obstetrics and Gynecology 2002 ACOG Practice Bulletin: diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 99:159-167
37. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL 1997 Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 349:1285-1288
38. Perkins AV, Linton EA, Eben F, Simpson J, Wolfe CD, Redman CW 1995 Corticotrophin-releasing hormone and corticotrophin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies. Br J Obstet Gynaecol 102:118-122
39. Laivuori H, Gallaher MJ, Collura L, Crombleholme WR, Markovic N, Rajakumar A, Hubel CA, Roberts JM, Powers RW 2006 Relationships between maternal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without preeclampsia. Mol Hum Reprod 12:551-556
40. Li RH, Poon SC, Yu MY, Wong YF 2004 Expression of placental leptin and leptin receptors in preeclampsia. lnt J Gynecol Pathol 23:378-385
41. Lu D, Yang X, Wu Y, Wang H, Huang H, Dong M 2006 Serum adiponectin, leptin and soluble leptin receptor in pre-eclampsia. lnt J Gynaecol Obstet 95:121-126
42. McCarthy JF, Misra DN, Roberts JM 1999 Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol 180:731-736
43. Tommaselli GA, Pighetti M, Nasti A, D'Elia A, Guida M, Di Carlo C, Bifulco G, Nappi C 2004 Serum leptin levels and uterine Doppler flow velocimetry at 20 weeks" gestation as markers for the development of pre-eclampsia. Gynecol Endocrinol 19:160-165
44. Vitoratos N, Chrystodoulacos G, Kouskouni E, Salamalekis E, Creatsas G 2001 Alterations of maternal and fetal leptin concentrations in hypertensive disorders of pregnancy. Eur J Obstet Gynecol Reprod Biol 96:59-62
45. Reimer T, Koczan D, Gerber B, Richter D, Thiesen HJ, Friese K 2002 Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes. Mol Hum Reprod 8:674-680
46. Tsoi SC, Cale JM, Bird IM, Kay HH 2003 cDNA microarray analysis of gene expression profiles in human placenta: up-regulation of the transcript encoding muscle subunit of glycogen phosphorylase in preeclampsia. J Soc Gynecol Investig 10:496-502
47. Gack S, Marme A, Marme F, Wrobel G, Vonderstrass B, Bastert G, Lichter P, Angel P, Schorpp-Kistner M 2005 Preeclampsia: increased expression of soluble ADAM 12. J Mol Med 83:887-89 452-462
48. Ness RB, Roberts JM 1996 Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175:1365-1370
49. Redman CW, Sargent IL 2005 Latest advances in understanding preeclampsia. Science 308:1592-1594
50. Laivuori H, Kaaja R, Koistinen H, Karonen SL, Andersson S, Koivisto V, Ylikorkala O 2000 Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity. Metabolism 49:259-263
51. Mise H, Sagawa N, Matsumoto T, Yura S, Nanno H, Itoh H, Mori T, Masuzaki H, Hosoda K, Ogawa Y, Nakao K 1998 Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. J Clin Endocrinol Metab 83:3225-3229
52. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N 2004 Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauter-ine growth restriction: relevance of adiposity. J Hypertens 22:2177-2183
53. Muy-Rivera M, Ning Y, Frederic IO, Vadachkoria S, Luthy DA, Williams MA 2005 Leptin, soluble leptin receptor and leptin gene polymorphism in relation to preeclampsia risk. Physiol Res 54:167-174
54. Varki A, Angata T 2006 Siglecs: the major subfamily of I-type lectins. Gly-cobiology 16:1R-27R
55. Chez RA 1976 Nonhuman primate models of toxemia of pregnancy. Perspect Nephrol Hypertens 5:421-424
56. Schulz LC, Townsend K, Kunz TH, Widmaier EP 2007 Inhibition of tropho-blast invasiveness in vitro by immuno neutralization of leptin in the bat, Myotis lucifugus (Chiroptera). Gen Comp Endocrinol 150:59-65
57. Schulz LC, Widmaier EP 2004 The effect of leptin on mouse trophoblast cell invasion. Biol Reprod 71:1963-1967
58. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
59. Xu Q, Yan B, Li S, Duan C 2004 Fibronectin binds insulin-like growth factor-binding protein 5 and abolishes its ligand-dependent action on cell migration. J Biol Chem 279:4269-4277
60. Fruhbeck G 2006 Intracellular signalling pathways activated by leptin. Biochem] 393:7-20
61. Howard JK, Flier JS 2006 Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab 17:365-371
62. Orr SJ, Morgan NM, Buick RJ, Boyd CR, Elliott J, Burrows JF, Jefferies CA, Crocker PR, Johnston JA 2007 SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses. J Biol Chem 282: 3418-3422
63. Orr SJ, Morgan NM, Elliott J, Burrows JF, Scott CJ, McVicar DW, Johnston JA 2007 CD33 responses are blocked by SOCS3 through accelerated protea-somal-mediated turnover. Blood 109:1061-1068